Biotanika will perform additional research on multi-herb nutraceutical
products in PEI research facilities
QUEBEC CITY, April 15 /CNW Telbec/ - Biotanika Health Group Inc.
("Biotanika") and the National Research Council Institute for Nutrisciences
and Health ("NRC-INH") are reaching beyond borders in an innovative research
project on multi-herb nutraceuticals for pain relief. The Atlantic Canada
Opportunities Agency ("ACOA"), through its Business Development Program, have
confirmed a $251,100 investment towards a $436,000 development project to be
researched at the Charlottetown-based NRC-INH and managed by Biotanika.
Bioscience communities on Prince Edward Island and natural health product
communities across North America will benefit as a result of this pioneering
research and development.
This financial support from ACOA allows Biotanika to continue its
innovative project to develop and patent natural health formulas against pain
and inflammation in dogs and cats, as well as in humans. Working with
scientists from the NRC-INH enlisted for their expertise in inflammation and
pain, Biotanika intends to derive these potent formulations from multi-herb
extracts. These new products will be manufactured by a PEI company, for
distribution in North America first, and will be marketed exclusively through
veterinarians and health care practitioners as an alternative to non-steroidal
anti-inflammatory drugs (NSAID).
"We are proud to collaborate with ACOA and to continue our valuable
partnership with the NRC-INH in bringing an innovative and highly credible
approach for the development of natural health products to the nutraceutical
market", said Benoit Côte, President and CEO of Biotanika. "The positive
support from ACOA is crucial to Biotanika and confirms that our innovative
development programs are considered with interest and respect by credible and
recognized organizations", he concluded.
Canadians want to know and ensure that natural health products are
effective, safe and of high quality. The research program is expected to
produce intellectual property for safe natural health products based on
Biotanika specializes in the development and distribution of
naturally-based products. These products, with proven efficacy, provide an
alternative to prescription drugs to people suffering from pathologies
affecting their quality of life.
Biotanika Health is a commercial unit addressing the human health market
and Biotanika Animal is a commercial unit addressing the companion animal
For more information, visit www.biotanika.com
For further information:
For further information: Benoit Côte, President and CEO, Biotanika
Health Group Inc., (418) 653-3423 x1701, email@example.com